Failed biotechs tout cash to attract buyers
Thursday, September 25, 2008 - 08:56
in Mathematics & Economics
BOSTON (Reuters) - Small biotechnology companies with cash but failed or floundering products are in hot demand as partners for companies that are unable to raise money in the capital markets.